This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Facioscapulohumeral muscular dystrophy (FSHD) is an enigmatic genetic disorder with consistent major effects on skeletal muscle and less consistent effects on other tissues. Although the location of a causative genetic disturbance has been identified at one end of chromosome 4, the full nature of the disturbance and how this produces the disease is unclear. The study of the relationship between the genetic abnormalities present and the production of disease in FSHD promises not only to benefit the care of patients with FSHD and further our understanding of skeletal muscle biology, but also to shed fundamental light on basic mechanisms of gene regulation and human genetics.
The genetic disturbance present in almost all people with FSHD is of a peculiar nature. It consists of an uncommon deletion of a region at the distal end of chromosome 4q combined with the presence of one of two common sequence variants distal to this deleted region. Both are necessary. Furthermore, unlike the majority of other genetic disorders, the mutant FSHD deleted region does not include any known transcribed sequences. In this issue of Neurology, two articles advance our understanding of FSHD.1,2 One provides compelling data pertaining to a new hypothesis for the disease mechanism and insight into the relationship between gene expression and nonmuscle systemic disease in FSHD, and the other adds to defining the minimal genetic requirement for the disease.
The article by Osborne …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.